Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JPMorgan Chase & Co. (JPM): An Insider’s Spouse and Related Companies Bought In

Page 1 of 2

On April 19th, the spouse of JPMorgan Chase & Co. (NYSE:JPM) Board member James Crown purchased 5,000 shares of stock at an average price of $46.99 per share, and between the 19th and the 22nd a number of companies tied to Crown (including The Crown Fund, which manages much of the Crown family’s wealth) bought over 400,000 shares of the bank. Insider purchases tend to be bullish signals (read our analysis of studies on insider trading), and we think that this is because insiders already have an economic connection to the company and so should generally prefer to diversify their wealth. While Crown did not increase his direct holdings (which were reported as almost 260,000 shares), we think it’s safe to assume that his spouse’s purchase at least would be unwise without some degree of confidence in JPMorgan Chase’s prospects. It’s also interesting to note that just a few days ago we had reported on a large insider purchase at Bank of America Corp (NYSE:BAC). Learn more about the insider buy at Bank of America.

JPMorgan Chase & Co. (NYSE:JPM) recently reported its results for the first quarter of 2013. While total net revenue decreased slightly versus a year earlier, the bank slashed its noninterest expenses by 16% and so was able to deliver a 33% increase in net income. We would note that revenue and earnings were both up on a q/q basis. Book value increased yet again, to $52 per share, and tangible book value rose to nearly $40. Currently JPMorgan Chase trades at a small discount to the book value of its equity, with a P/B ratio of 0.9, and at only 9 times its trailing earnings- making it an interesting value prospect in our view.


JPMorgan Chase & Co. (NYSE:JPM) had been one of the most financial stocks among hedge funds in the fourth quarter of 2012 (find more financial stocks hedge funds loved), according to our database of 13F filings. We track these filings to help us research investing strategies (for example, we have found that the most popular small cap stocks among hedge funds outperform the S&P 500 by 18 percentage points per year on average) but they also come in handy for finding individual funds and other notable investors who like particular stocks. We can see that billionaire Ken Fisher’s Fisher Asset Management disclosed ownership of almost 12 million shares at the end of December (check out more stocks Fisher owned) while billionaire Louis Bacon’s Moore Global increased its stake by 33% to a total of 5.1 million shares (see Bacon’s stock picks).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!